CRL — Charles River Laboratories International, Inc.
$337.97
$-2.84 (-0.83%)
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers.
Market Cap
$16.19B
Forward P/E
26.1x
52-Week Range
N/A
CRL Price History
Revenue vs. Net Income
$4B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$518M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
0.1%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.8x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
5.5%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-4.0%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
